Correction to: Nature Reviews Immunology https://doi.org/10.1038/s41577-021-00583-2, published online 26 July 2021.
In Figure 2 describing the ‘Licensed mucosal vaccines’ the green box detailing the rotavirus vaccines was incorrectly labelled as ‘Poliovirus’ in the originally published version. Further, in the peach “Vibrio cholerae” box, the composition for Vaxchora inadvertently duplicated text from the box above and has been amended to read “live attenuated 01 serogroup (Inaba) - ctxA attenuation.” This has all now been corrected and we apologize for the errors.
Change history
26 September 2022
In the version of this amendment initially published, errors in text for Fig. 2 Vibrio cholerae Vaxchora were not listed and have now been included.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lavelle, E.C., Ward, R.W. Publisher Correction: Mucosal vaccines — fortifying the frontiers. Nat Rev Immunol 22, 266 (2022). https://doi.org/10.1038/s41577-021-00599-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-021-00599-8
This article is cited by
-
The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
Signal Transduction and Targeted Therapy (2023)
-
Assessing the generation of tissue resident memory T cells by vaccines
Nature Reviews Immunology (2023)
